COVEX IS A SPANISH COMPANY based in Colmenar Viejo, Madrid, Spain. Since its inception in 1977 it has specialized in the manufacturing, development and commercialization of chemical and pharmaceutical products.

Covex's contribution to Spanish commercial exports was officially recognized by the Chamber of Commerce & Industry of Madrid in 1992 when the company was awarded the "Premio a la Exportacion" (Export Prize). Recently, Covex created a company in the USA called Covex Pharma Inc. This company entered an exclusive distribution agreement with Kingchem Inc. to market and distribute Vinpocetine on the U.S. market. Covex formed this business alliance for the introduction of Vinpocetine in the U.S.A. by joining mutual efforts in sales and marketing.

Virtually all age groups of the population should find Covex products useful, from students who wish to improve their intellectual capacity to the elderly who already suffer from senile dementia, as well as the middle-aged who have begun to notice dementia symptoms. All the products are backed by over 20 years of scientific research, numerous clinical studies and publications in science and trade magazines.

After a quarter of a century of research and development Covex, a company that began modestly on the outskirts of Madrid, Spain, is now firmly established and leading in the production of the periwinkle family products in the world.

Over the last 15 years Covex has exported more than 95% of its production to over 55 countries and now has affiliates in nine countries around the world.

Covex has experienced a significant growth in international markets during the last few years. Covex is the largest Spanish pharmaceutical company exporting to Russia.

The company's activities are based on the quality and competitive prices of our products. Presently, the company holds more than 110 patents in over 100 countries. Actually, we have fully set up subsidiaries worldwide, including USA, Hong Kong, Russia, Lithuania, Portugal, Hungary, Japan and Poland.